0001104659-24-002378.txt : 20240108
0001104659-24-002378.hdr.sgml : 20240108
20240108211202
ACCESSION NUMBER: 0001104659-24-002378
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240104
FILED AS OF DATE: 20240108
DATE AS OF CHANGE: 20240108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pichl Daniel
CENTRAL INDEX KEY: 0001819465
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39044
FILM NUMBER: 24521572
MAIL ADDRESS:
STREET 1: C/O SPRINGWORKS THERAPEUTICS, INC.
STREET 2: 100 WASHINGTON BLVD.
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc.
CENTRAL INDEX KEY: 0001773427
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-883-9490
MAIL ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
tm242462-7_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-04
0
0001773427
SpringWorks Therapeutics, Inc.
SWTX
0001819465
Pichl Daniel
C/O SPRINGWORKS THERAPEUTICS, INC.
100 WASHINGTON BLVD.
STAMFORD
CT
06902
0
1
0
0
Chief People Officer
0
Common Stock
2024-01-04
4
A
0
22919
0.00
A
58122
D
Common Stock
2024-01-05
4
F
0
1574
37.96
D
56548
D
Common Stock
2024-01-08
4
F
0
1405
41.53
D
55143
D
Stock Option (Right to Buy)
38.40
2024-01-04
4
A
0
65000
0
A
2034-01-03
Common Stock
65000
65000
D
This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty-three percent (33%) to vest on January 4, 2025, another thirty-three percent (33%) to vest on January 4, 2026 and the remaining thirty-four percent (34%) to vest on January 4, 2027, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs and does not represent a sale by the Reporting Person.
This option shall vest in forty-eight (48) equal monthly installments following January 4, 2024, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
/s/ Francis I. Perier, Jr. as Attorney-in Fact
2024-01-08